Skip to content

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02416414
Enrollment
166
Registered
2015-04-15
Start date
2015-07-31
Completion date
2016-02-29
Last updated
2016-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cell-mediated Immune Response

Brief summary

To compare the performance of the QuantiFERON Monitor assay against existing methodology.

Interventions

DEVICEQuantiFERON Monitor Assay

Assay to measure cell-mediated immune function using QuantiFERON Monitor assay.

DEVICEExisting methodology

Assay to measure cell-mediated immune function using existing methodology.

Sponsors

QIAGEN Gaithersburg, Inc
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Solid Organ Transplant Recipient Inclusion Criteria: * Provide Informed Consent * Received a solid organ transplant

Exclusion criteria

* Pregnancy or recent lactation (\<1yr) * Treatment of Rejection Healthy Control Inclusion Criteria: * Provide Informed Consent

Design outcomes

Primary

MeasureTime frame
Cell-mediated immune response.1 day (At time of enrollment)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026